JLJohannes H. M. Levels

Johannes H. M. Levels

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Johannes H. M. Levels has a total of 50 co-authors. Here are the top co-authors by number of shared publications:

  • Helen Karlsson

    Department of Health, Medicine, and Caring Sciences, Linköping University, Linköping, Sweden; Clinical Department of Occupational and Environmental Medicine in Linköping, Region Östergötland, Linköping, Sweden

    2 shared publications
  • Joost C. M. Meijers

    Department of Experimental Vascular Medicine University of Amsterdam, Amsterdam UMC Amsterdam the Netherlands

    2 shared publications
  • Mats Lindahl

    Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden

    2 shared publications
  • P. R. Abraham

    Departments of Experimental Vascular Medicine,1 Experimental Internal Medicine,2 Gastroenterology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands3

    2 shared publications
  • S. J. H. van Deventer

    Departments of Experimental Vascular Medicine,1 Experimental Internal Medicine,2 Gastroenterology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands3

    2 shared publications
  • Stefan Ljunggren

    Occupational and Environmental Medicine Centre, Department of Health Medicine and Caring Sciences, Unit of Clinical Medicine, Linköping University, Linköping, Sweden

    2 shared publications

Latest Publications

  • Open Access

    NTCP deficiency in mice protects against obesity and hepatosteatosis

    by Joanne M. Donkers, Sander Kooijman, Davor Slijepcevic, Roni F. Kunst, Reinout L.P. Roscam Abbing, Lizette Haazen, Dirk R. de Waart, Johannes H.M. Levels, Kristina Schoonjans, Patrick C.N. Rensen, et al.

    Bile acids play a major role in the regulation of lipid and energy metabolism. Here we propose the hepatic bile acid uptake transporter Na + taurocholate cotransporting polypeptide (NTCP) as a target to prolong postprandial bile acid elevations in plasma. Reducing hepatic clearance of bile acids from plasma by genetic deletion of NTCP moderately increased plasma bile acid levels, reduced diet-induced obesity, attenuated hepatic steatosis, and lowered plasma cholesterol levels. NTCP and G protein–coupled bile acid receptor–double KO (TGR5–double KO) mice were equally protected against diet-induced obesity as NTCP–single KO mice. NTCP-KO mice displayed decreased intestinal fat absorption and a trend toward higher fecal energy output. Furthermore, NTCP deficiency was associated with an increased uncoupled respiration in brown adipose tissue, leading to increased energy expenditure. We conclude that targeting NTCP-mediated bile acid uptake can be a novel approach to treat obesity and obesity-related hepatosteatosis by simultaneously dampening intestinal fat absorption and increasing energy expenditure.


  • Lipoprotein profiles in human heterozygote carriers of a functional mutation P297S in scavenger receptor class B1

    by Stefan A. Ljunggren, Johannes H.M. Levels, Kees Hovingh, Adriaan G. Holleboom, Menno Vergeer, Letta Argyri, Christina Gkolfinopoulou, Angeliki Chroni, Jeroen A. Sierts, John J. Kastelein, et al.


  • Open Access

    High-density lipoprotein proteome dynamics in human endotoxemia

    by Johannes Hm Levels, Pierre Geurts, Helen Karlsson, Raphaël Marée, Stefan Ljunggren, Louise Fornander, Louis Wehenkel, Mats Lindahl, Erik Sg Stroes, Jan A Kuivenhoven, et al.

    A large variety of proteins involved in inflammation, coagulation, lipid-oxidation and lipid metabolism have been associated with high-density lipoprotein (HDL) and it is anticipated that changes in the HDL proteome have implications for the multiple functions of HDL. Here, SELDI-TOF mass spectrometry (MS) was used to study the dynamic changes of HDL protein composition in a human experimental low-dose endotoxemia model. Ten healthy men with low HDL cholesterol (0.7+/-0.1 mmol/L) and 10 men with high HDL cholesterol levels (1.9+/-0.4 mmol/L) were challenged with endotoxin (LPS) intravenously (1 ng/kg bodyweight). We previously showed that subjects with low HDL cholesterol are more susceptible to an inflammatory challenge. The current study tested the hypothesis that this discrepancy may be related to differences in the HDL proteome.


  • Alterations in lipoprotein homeostasis during human experimental endotoxemia and clinical sepsis

    by Johannes H.M. Levels, Dasja Pajkrt, Marcus Schultz, Frans J. Hoek, Arie van Tol, Joost C.M. Meijers, Sander J.H. van Deventer


  • Open Access

    SELDI-TOF mass spectrometry of High-Density Lipoprotein

    by Johannes Hm Levels, Boris Bleijlevens, Farhad Rezaee, Johannes Mfg Aerts, Joost Cm Meijers

    High-Density Lipoprotein (HDL), one of the main plasma lipoproteins, serves as a docking station for proteins involved in inflammation, coagulation, and lipid metabolism.


  • Open Access

    Lipopolysaccharide Is Transferred from High-Density to Low-Density Lipoproteins by Lipopolysaccharide-Binding Protein and Phospholipid Transfer Protein

    by J. H. M. Levels, J. A. Marquart, P. R. Abraham, A. E. van Den Ende, H. O. F. Molhuizen, S. J. H. van Deventer, J. C. M. Meijers

    Lipopolysaccharide (LPS), the major outer membrane component of gram-negative bacteria, is a potent endotoxin that triggers cytokine-mediated systemic inflammatory responses in the host. Plasma lipoproteins are capable of LPS sequestration, thereby attenuating the host response to infection, but ensuing dyslipidemia severely compromises this host defense mechanism. We have recently reported thatEscherichia coliJ5 and Re595 LPS chemotypes that contain relatively short O-antigen polysaccharide side chains are efficiently redistributed from high-density lipoproteins (HDL) to other lipoprotein subclasses in normal human whole blood (ex vivo). In this study, we examined the role of the acute-phase proteins LPS-binding protein (LBP) and phospholipid transfer protein (PLTP) in this process. By the use of isolated HDL containing fluorescent J5 LPS, the redistribution of endotoxin among the major lipoprotein subclasses in a model system was determined by gel permeation chromatography. The kinetics of LPS and lipid particle interactions were determined by using Biacore analysis. LBP and PLTP were found to transfer LPS from HDL predominantly to low-density lipoproteins (LDL), in a time- and dose-dependent manner, to induce remodeling of HDL into two subpopulations as a consequence of the LPS transfer and to enhance the steady-state association of LDL with HDL in a dose-dependent fashion. The presence of LPS on HDL further enhanced LBP-dependent interactions of LDL with HDL and increased the stability of the HDL-LDL complexes. We postulate that HDL remodeling induced by LBP- and PLTP-mediated LPS transfer may contribute to the plasma lipoprotein dyslipidemia characteristic of the acute-phase response to infection.


  • Open Access

    Distribution and Kinetics of Lipoprotein-Bound Lipoteichoic Acid

    by Johannes H. M. Levels, Philip R. Abraham, Erik P. van Barreveld, Joost C. M. Meijers, Sander J. H. van Deventer

    Lipoteichoic acid (LTA), a major cell wall component of gram-positive bacteria, is an amphipathic anionic glycolipid with structural similarities to lipopolysaccharide (LPS) from gram-negative bacteria. LTA has been implicated as one of the primary immunostimulatory components that may trigger the systemic inflammatory response syndrome. Plasma lipoproteins have been shown to sequester LPS, which results in attenuation of the host response to infection, but little is known about the LTA binding characteristics of plasma lipid particles. In this study, we have examined the LTA binding capacities and association kinetics of the major lipoprotein classes under simulated physiological conditions in human whole blood (ex vivo) by using biologically active, fluorescently labeled LTA and high-performance gel permeation chromatography. The average distribution of an LTA preparation fromStaphylococcus aureusin whole blood from 10 human volunteers revealed that >95% of the LTA was associated with total plasma lipoproteins in the following proportions: high-density lipoprotein (HDL), 68% ± 10%; low-density lipoprotein (LDL), 28% ± 8%; and very low density lipoprotein (VLDL), 4% ± 5%. The saturation capacity of lipoproteins for LTA was in excess of 150 μg/ml. The LTA distribution was temperature dependent, with an optimal binding between 22 and 37°C. The binding of LTA by lipoproteins was essentially complete within 10 min and was followed by a subsequent redistribution from HDL and VLDL to LDL. We conclude that HDL has the highest binding capacity for LTA and propose that the loading and redistribution of LTA among plasma lipoproteins is a specific process that closely resembles that previously described for LPS (J. H. M. Levels, P. R. Abraham, A. van den Ende, and S. J. H. van Deventer, Infect. Immun.68:2821-2828, 2001).


  • Distribution and Kinetics of Lipoprotein-Bound Endotoxin

    by J. H. M. Levels, P. R. Abraham, A. van Den Ende, S. J. H. van Deventer

    Lipopolysaccharide (LPS), the major glycolipid component of gram-negative bacterial outer membranes, is a potent endotoxin responsible for pathophysiological symptoms characteristic of infection. The observation that the majority of LPS is found in association with plasma lipoproteins has prompted the suggestion that sequestering of LPS by lipid particles may form an integral part of a humoral detoxification mechanism. Previous studies on the biological properties of isolated lipoproteins used differential ultracentrifugation to separate the major subclasses. To preserve the integrity of the lipoproteins, we have analyzed the LPS distribution, specificity, binding capacity, and kinetics of binding to lipoproteins in human whole blood or plasma by using high-performance gel permeation chromatography and fluorescent LPS of three different chemotypes. The average distribution of O111:B4, J5, or Re595 LPS in whole blood from 10 human volunteers was 60% (±8%) high-density lipoprotein (HDL), 25% (±7%) low-density lipoprotein, and 12% (±5%) very low density lipoprotein. The saturation capacity of lipoproteins for all three LPS chemotypes was in excess of 200 μg/ml. Kinetic analysis however, revealed a strict chemotype dependence. The binding of Re595 or J5 LPS was essentially complete within 10 min, and subsequent redistribution among the lipoprotein subclasses occurred to attain similar distributions as O111:B4 LPS at 40 min. We conclude that under simulated physiological conditions, the binding of LPS to lipoproteins is highly specific, HDL has the highest binding capacity for LPS, the saturation capacity of lipoproteins for endotoxin far exceeds the LPS concentrations measured in clinical situations, and the kinetics of LPS association with lipoproteins display chemotype-dependent differences.